Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06433219
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2024-05-22
Brief Title:
Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer DDRiver EOC 302
Sponsor:
EMD Serono Research Development Institute Inc
Organization:
EMD Serono
Organization Data
Organization:
EMD Serono
Class:
INDUSTRY
Study ID:
MS201924_0002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
EMD Serono Research Development Institute Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck KGaA Darmstadt Germany | INDUSTRY |